Kidney transplantation in patients with type I diabetes: 26-year experience at the University of Minnesota.
With current immunosuppressive protocols, 1- and 6-year graft survival is similar in diabetic and nondiabetic kidney transplant recipients. Living-donor transplant recipients have significantly better outcome. Death with function and chronic rejection remain the 2 predominant causes of graft loss for diabetic recipients. Compared with national statistics on diabetic patient survival on dialysis, our data suggest that transplantation is the treatment of choice for diabetic patients with end-stage renal disease.
Basadonna
G
G
Department of Surgery, University of Minnesota Hospital, Minneapolis.
Matas
A J
AJ
Gillingham
K
K
Sutherland
D E
DE
Payne
W D
WD
Dunn
D L
DL
Gores
P F
PF
Gruessner
R W
RW
Arrazola
L
L
Najarian
J S
JS
D000293:Adolescent; D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D005260:Female; D006085:Graft Survival; D006785:Hospitals, University; D006801:Humans; D016030:Kidney Transplantation / Q000401:mortality / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D008910:Minnesota / Q000453:epidemiology; D015996:Survival Rate